Jilin Aodong Pharmaceutical Group Future Growth
Future criteria checks 3/6
Jilin Aodong Pharmaceutical Group is forecast to grow earnings at 52.9% per annum. EPS is expected to grow by 50% per annum.
Key information
52.9%
Earnings growth rate
50.0%
EPS growth rate
| Pharmaceuticals earnings growth | 18.9% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | 17 Jun 2024 |
Recent future growth updates
No updates
Recent updates
A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)
Aug 22
Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60
Jul 05Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)
Jun 03There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings
Apr 23Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 6/30/2024 | 3,278 | 934 | -160 | 333 | N/A |
| 3/31/2024 | 3,523 | 1,118 | -164 | 286 | N/A |
| 12/31/2023 | 3,449 | 1,460 | -351 | 68 | N/A |
| 9/30/2023 | 3,309 | 2,175 | -264 | 94 | N/A |
| 6/30/2023 | 3,201 | 2,349 | -157 | 101 | N/A |
| 3/31/2023 | 3,019 | 2,207 | 35 | 299 | N/A |
| 1/1/2023 | 2,868 | 1,781 | 153 | 424 | N/A |
| 9/30/2022 | 2,618 | 968 | -100 | 171 | N/A |
| 6/30/2022 | 2,471 | 1,313 | -216 | 92 | N/A |
| 3/31/2022 | 2,417 | 1,448 | -46 | 262 | N/A |
| 1/1/2022 | 2,304 | 1,781 | 12 | 325 | N/A |
| 9/30/2021 | 2,234 | 1,898 | -55 | 231 | N/A |
| 6/30/2021 | 2,213 | 1,651 | 45 | 324 | N/A |
| 3/31/2021 | 2,307 | 1,772 | 25 | 296 | N/A |
| 12/31/2020 | 2,252 | 1,709 | 163 | 390 | N/A |
| 9/30/2020 | 2,346 | 1,748 | 318 | 549 | N/A |
| 6/30/2020 | 2,567 | 1,552 | 407 | 600 | N/A |
| 3/31/2020 | 2,734 | 1,087 | 275 | 450 | N/A |
| 12/31/2019 | 3,088 | 1,404 | 157 | 379 | N/A |
| 9/30/2019 | 3,286 | 1,199 | 34 | 221 | N/A |
| 6/30/2019 | 3,386 | 1,199 | 87 | 275 | N/A |
| 3/31/2019 | 3,439 | 1,255 | 0 | 302 | N/A |
| 12/31/2018 | 3,324 | 935 | 102 | 348 | N/A |
| 9/30/2018 | 3,386 | 1,390 | 184 | 428 | N/A |
| 6/30/2018 | 3,332 | 1,560 | 152 | 371 | N/A |
| 3/31/2018 | 3,183 | 1,770 | N/A | 273 | N/A |
| 12/31/2017 | 2,977 | 1,863 | N/A | 256 | N/A |
| 9/30/2017 | 2,869 | 1,754 | N/A | 277 | N/A |
| 6/30/2017 | 2,745 | 1,739 | N/A | 281 | N/A |
| 3/31/2017 | 2,670 | 1,721 | N/A | 361 | N/A |
| 12/31/2016 | 2,737 | 1,666 | N/A | 334 | N/A |
| 9/30/2016 | 2,543 | 1,857 | N/A | 379 | N/A |
| 6/30/2016 | 2,413 | 1,772 | N/A | 416 | N/A |
| 3/31/2016 | 2,378 | 2,370 | N/A | 374 | N/A |
| 12/31/2015 | 2,335 | 2,594 | N/A | 388 | N/A |
| 9/30/2015 | 2,241 | 2,515 | N/A | 422 | N/A |
| 6/30/2015 | 2,244 | 2,530 | N/A | 315 | N/A |
| 3/31/2015 | 2,241 | 1,767 | N/A | 325 | N/A |
| 12/31/2014 | 2,240 | 1,411 | N/A | 289 | N/A |
| 9/30/2014 | 2,271 | 1,274 | N/A | 171 | N/A |
| 6/30/2014 | 2,227 | 1,175 | N/A | 267 | N/A |
| 3/31/2014 | 2,091 | 1,097 | N/A | 209 | N/A |
| 12/31/2013 | 1,957 | 1,059 | N/A | 201 | N/A |
| 9/30/2013 | 1,752 | 800 | N/A | 235 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000623's forecast earnings growth (52.9% per year) is above the savings rate (2.9%).
Earnings vs Market: 000623's earnings (52.9% per year) are forecast to grow faster than the CN market (22.9% per year).
High Growth Earnings: 000623's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 000623's revenue is forecast to grow faster than the CN market.
High Growth Revenue: Insufficient data to determine if 000623's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 000623's Return on Equity is forecast to be high in 3 years time